Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 14;40(4):285–297. doi: 10.1016/0165-2427(94)90040-X

Seroepidemiological and clinical survey of feline immunodeficiency virus infection in northern Italy

Enzo V Peri a,∗, Wilma Ponti a, Paola Dall'ara a, Mara Rocchi a, Alfonso Zecconi b, Luigi Bonizzi a
PMCID: PMC7119872  PMID: 8042281

Abstract

Four hundred and thirty-nine feline serum samples from cats with different living conditions in the north of Italy were tested for antibodies to feline immunodeficiency virus (FIV) and for antigen of Feline Leukemia Virus by enzyme-linked immunosorbent assay. A Western blot technique was also used on the positive sera in order to confirm the presence of specific antibodies to FIV. The Western blot enabled the detection of a false positive serum. The prevalence of FIV infection in this population was 12.5% and among the seropositive cats a greater proportion was male (74.5%) than female (25.5%). A correlation between the clinical status and the evolution of the pathology is described together with a score based on the severity of the stomatitis in infected cats. The Western blot patterns of positive samples were then compared with the stage of the pathology. Statistical analysis on the distribution of FIV in stray cats, cats with garden and courtyard access and strictly house-confined cats showed a highly significant risk of the infection in the first group.

Abbreviations: AC, asymptomatic carrier; BSA, bovine serum albumin; ELISA, enzyme-linked immunosorbent assay; FIV, feline immunodeficiency virus; HIV, human immunodeficiency virus; PGL, persistent generalized lymphoadenopathy; SDS, sodium dodecylsulfate; TBS, Tris-buffered saline

References

  1. Gardner M.B. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Antiviral Res. 1991;15:267–286. doi: 10.1016/0166-3542(91)90009-g. [DOI] [PubMed] [Google Scholar]
  2. Gruffyd-Jones T.J., Hopper C.D., Harbour D.A., Lutz H. Serological evidence of Feline Immunodeficiency Virus infection in United Kingdom cats from 1975–1976. Vet. Rec. 1988;123:569–670. doi: 10.1136/vr.123.22.569. [DOI] [PubMed] [Google Scholar]
  3. Hosie M.J., Roberson C., Jarret O. Prevalence of Feline Leukemia Virus and antibodies to Feline Immunodeficiency virus in cats in the United Kingdom. Vet. Rec. 1989;128:293–297. doi: 10.1136/vr.125.11.293. [DOI] [PubMed] [Google Scholar]
  4. Hosmer D.W., Lemeshow S. John Wiley; New York: 1989. Applied logistic regression; pp. 1–307. [Google Scholar]
  5. Ishida T., Tomoda I. Clinical staging of Feline Immunodeficiency Virus. Jpn. J. Vet. Sci. 1990;52(3):645–648. doi: 10.1292/jvms1939.52.645. [DOI] [PubMed] [Google Scholar]
  6. Ishida T., Washizu T., Toriyabe K., Motoyoshi S., Pedersen N.C. Feline Immunodeficiency Virus infection in cats of Japan. J. Am. Vet. Med. Assoc. 1989;194:221–225. [PubMed] [Google Scholar]
  7. Ishida T., Taniguchi A., Matsumura S., Washizu T., Tomoda I. Long-term clinical observations on feline immunodeficiency virus infected asymptomatic carriers. Vet. Immunol. Immunopathol. 1992;35:15–22. doi: 10.1016/0165-2427(92)90117-9. [DOI] [PubMed] [Google Scholar]
  8. Kolbl S., Lutz H. Die infektion mit felinem spumavirus (FeSFV): haufigkeit bei katzen in Osterreich und beziehung zur infektion mit dem felinen immunshwachevirus (FIV) Kleintierpraxis. 1992;37:307–318. [Google Scholar]
  9. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriofage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  10. Lutz H. Feline retroviruses: a brief review. Vet. Microbiol. 1990;23:131–146. doi: 10.1016/0378-1135(90)90143-j. [DOI] [PubMed] [Google Scholar]
  11. Lutz H., Arnold P., Hubscher U., Egberink H., Pedersen N., Horzinek M.C. Specifity assessment of feline T-lymphotropic lentivirus serology. J. Vet. Med. (B) 1988;35:773–778. doi: 10.1111/j.1439-0450.1988.tb00559.x. [DOI] [PubMed] [Google Scholar]
  12. Lutz H., Lehmann R., Winkler G., Kottwitz B., Dittmer A., Wolfensberger C., Arnold P. Das feline immunshwachevirus in der Schweiz: klinik und epidemiologie im vergleich mit dem leukamie- und dem coronavirus. Schweiz. Arch. Tierheilkd. 1990;132:217–225. [PubMed] [Google Scholar]
  13. Narayan O. Lentiviruses are etiological agents of chronic diseases in animals and acquired immunodeficiency syndrome in humans. Cancer J. Vet. Res. 1990;54:42–48. [PMC free article] [PubMed] [Google Scholar]
  14. Pedersen N.C. Feline Immunodeficiency Virus infection. In: Schellekens H., Horzinek M.C., editors. Animal Models in AIDS. Elsevier; Amsterdam: 1990. pp. 165–183. [Google Scholar]
  15. Pedersen N.C., Ho E.W., Brown M.L., Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 1987;235:790–793. doi: 10.1126/science.3643650. [DOI] [PubMed] [Google Scholar]
  16. Sabine M., Michelsen J., Thomas F., Zheng M. Feline AIDS. Aust. Vet. Pract. 1988;18:105–107. [Google Scholar]
  17. Shelton G.H., Grant C.K., Cotter S.M., Gardner M.S., Hardy W.D., di Giacomo R.F. Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV) infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968–1987) J. AIDS. 1990;3:623–630. [PubMed] [Google Scholar]
  18. Statistical Analysis Systems . Version 6.03. Edition. SAS Institute Inc; Cary, NC: 1987. SAS User's Guide: Statistics; pp. 189–282. [Google Scholar]
  19. Talbott R.L., Sparger E.E., Lovelace K.M., Fitch W.M., Pedersen N.C., Luciw P.A., Elder J.H. Vol. 86. 1989. Nucleotide sequence and genomic organization of Feline Immunodeficiency Virus; pp. 5743–5747. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yamamoto J.K., Sparger E., Ho E.W., Andersen P.R., O'Connor T., Mandell C.P., Lowenstine L., Munn R., Pedersen N.C. Pathogenesis of experimentally induced Feline Immunodeficiency Virus infection in cats. Am. J. Vet. Res. 1988;49:1246–1258. [PubMed] [Google Scholar]
  21. Yamamoto J.K., Hansen H., Ho E.W., Morishita T.Y., Okuda T., Sawa T.R., Nakamura R.M., Pedersen N.C. Epidemiologic and clinical aspects of Feline Immunodeficiency Virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 1989;194:213–220. [PubMed] [Google Scholar]
  22. Yamamoto J.K., Okuda T., Ackley C.D., Lovie H., Pembroche E., Zochlinsky H., Munn R., Gardner M.B. Experimental vaccine protection against Feline Immunodeficiency Virus. AIDS Res. Hum. Retroviruses. 1991;7:911–922. doi: 10.1089/aid.1991.7.911. [DOI] [PubMed] [Google Scholar]

Articles from Veterinary Immunology and Immunopathology are provided here courtesy of Elsevier

RESOURCES